Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia

Biological Psychiatry

Volumn 44, Issue 6, 1998, Pages 423-427

  Simpson, M D C ^a   Slater, Paul ^a   Deakin, J F W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

3H nipecotic acid binding; D 3H aspartate binding; Postmortem brain; Prefrontal cortex; Schizophrenia; Temporal lobes

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID;

ADULT; AMINO ACID BRAIN LEVEL; ARTICLE; AUTOPSY; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL LOBE; THEORY;

AGED; ASPARTIC ACID; CHRONIC DISEASE; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; NIPECOTIC ACIDS; PROLINE; RECEPTORS, GABA; RECEPTORS, GLUTAMATE; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 0032530782     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00077-8     Document Type: Article

References (22)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E., et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52:1995;258-266.
2. Benes F.M., Sorensen I., Vincent S.L., Bird E.D., Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex. 2:1992;503-512.
3. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 75:1996;1021-1031.
4. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophr Bull. 19:1993;431-445.
5. Deakin J.F.W., Slater P., Simpson M.D.C., Gilchrist A.C., Skan W.J., Royston M.C., et al. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem. 52:1989;1781-1786.
6. 3H]Muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sci. 40:1987;259-266.
7. Hellewell J.S.E., Deakin J.F.W. Impaired frontal lobe function in schizophrenia is familial. Schizophr Res. 11:1994;149.
8. Ishimaru M., Kurumaji A., Toru M. Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics Evidence for glutamate hypothesis . Biol Psychiatry. 35:1994;84-95.
9. Kerwin R.W., Patel S., Meldrum B.S. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience. 39:1990;25-32.
10. Kirkby B.S., Berman K.F., Weinberger D.R. Neurodevelopment and schizophrenia The contribution of functional brain imaging . Waddington J.L., Buckley P.F. The Neurodevelopmental Basis of Schizophrenia. 1996;119-133 RG Landes, Austin, TX.
11. Lim K.O., Tew W., Kushner M., Chow K., Matsumoto B., DeLisi L.E. Cortical gray matter volume deficit in patients with first-episode schizophrenia. Am J Psychiatry. 153:1996;1548-1553.
12. 3H]AMPA binding in frontal cortex in schizophrenia. Schizophr Res. 11:1994;121.
13. Reynolds G.P. Amino acid transmitters and dopamine function in the brain in schizophrenia. Racagni G., Brunello N., Fokuda T. Biological Psychiatry. vol 1:1991;491-494 Excerpta Medica, Amsterdam.
14. Reynolds G.P., Czudek C., Andrews H.B. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol Psychiatry. 27:1990;1038-1044.
15. Simpson M.D.C., Cross A.J., Slater P., Deakin J.F.W. GABA uptake sites in Alzheimer's disease. J Neural Transm Gen Sect. 71:1988;219-226.
16. Simpson M.D.C., Slater P., Deakin J.F.W., Royston M.C., Skan W.J. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci Lett. 107:1989;211-215.
17. Simpson M.D.C., Royston M.C., Slater P., Deakin J.F.W. Neurochemical abnormalities of the cerebral cortex in schizophrenia. Schizophr Res. 6:1992;133-134.
18. 1A receptors in ventral prefrontal cortex in schizophrenia. Biol Psychiatry. 39:1996;919-928.
19. 3H]MK-801 binding in human temporal cortex. Br J Pharmacol. 108:1993;1143-1149.
20. Toru M., Watanabe S., Shibuya H., Nishikawa T., Noda K., Mitsushio H., et al. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr Scand. 78:1988;121-137.
21. Ulas J., Cotman C.W. Excitatory amino acid receptors in schizophrenia. Schizophr Bull. 19:1993;105-117.
22. Weinberger D.R. Schizophrenia as a neurodevelopmental disorder. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;293-323 Blackwell, Oxford.